Application of Tumor Markers CEA, TPA, and SCC-Ag in Patients with Low-Risk FIGO Stage IB and IIA Squamous Cell Carcinoma of the Uterine Cervix

This publication has 19 references indexed in Scilit:

• Immunocytological Distribution of the Tumor Antigen
  Asia-Oceania Journal of Obstetrics and Gynaecology, 2010
• Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma
  European Journal Of Cancer, 1992
• Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum ca 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics
  Cancer, 1990
• Experiences with SCC antigen, a new tumor marker for cervical carcinoma
  European Journal of Cancer and Clinical Oncology, 1989
• Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer
  Gynecologic Oncology, 1989
• The clinical value of tissue polypeptide antigen in patients with gynecologic tumors
  Cancer, 1985
• The prognostic significance of carcinoembryonic antigen determinations in patients with adenocarcinoma of the cervix
  Gynecologic Oncology, 1984
• Carcinoembryonic antigen in carcinoma of the uterine cervix. 1. The prognostic value of serial plasma determinations
  Cancer, 1978
• Carcinoembryonic Antigen Levels in Patients With Squamous Cell Carcinoma of the Cervix
  Obstetrics & Gynecology, 1978
• Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma
  Cancer, 1977